Click here to see an annotated bibliography of the data in the table.
This is a table of authors, titles, dates and other bibliographic information; it is a list metadata describing the content of your study carrel. Think of it as your library.
| id | author | title | date | words | sentences | text |
|---|---|---|---|---|---|---|
| cord-280939-d478p8u6 | Abe, Kento T. | A simple protein-based surrogate neutralization assay for SARS-CoV-2 | 2020-10-02 | 7576.0 | 380.0 | view text |
| cord-333089-ufyzqgqk | Aguilar-Pineda, Jorge Alberto | Structural and functional analysis of female sex hormones against SARS-Cov2 cell entry | 2020-07-29 | 6957.0 | 359.0 | view text |
| cord-356264-q0yqnlyl | Armijos-Jaramillo, Vinicio | SARS-CoV-2, an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability | 2020-03-23 | 4974.0 | 253.0 | view text |
| cord-323324-h2a25xym | Armijos‐Jaramillo, Vinicio | SARS‐CoV‐2, an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability | 2020-05-07 | nan | nan | view text |
| cord-319855-78xmxymu | BR, Bharath | In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19 | 2020-07-01 | nan | nan | view text |
| cord-262043-66qle52a | Basit, Abdul | Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent | 2020-05-20 | 4866.0 | 275.0 | view text |
| cord-353748-y1a52z8e | Bhattacharya, Rajarshi | A natural food preservative peptide nisin can interact with the SARS-CoV-2 spike protein receptor human ACE2 | 2021-01-02 | 3308.0 | 211.0 | view text |
| cord-300707-k9uk14b3 | Bouwman, Kim M. | Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins | 2020-09-04 | nan | nan | view text |
| cord-328189-jpkxjn6e | Brielle, Esther S. | The SARS-CoV-2 exerts a distinctive strategy for interacting with the ACE2 human receptor | 2020-03-12 | 2971.0 | 172.0 | view text |
| cord-340960-abanr641 | Brigger, D. | Accuracy of serological testing for SARS‐CoV‐2 antibodies: first results of a large mixed‐method evaluation study | 2020-09-30 | 4479.0 | 289.0 | view text |
| cord-299783-8ti6r0eh | Bruni, M. | Persistence of anti-SARS-CoV-2 antibodies in non-hospitalized COVID-19 convalescent health care workers | 2020-08-01 | nan | nan | view text |
| cord-318018-ybdkp398 | Bruni, Margherita | Persistence of Anti-SARS-CoV-2 Antibodies in Non-Hospitalized COVID-19 Convalescent Health Care Workers | 2020-10-01 | 5481.0 | 263.0 | view text |
| cord-326337-s0fp5z1q | Chan, Kui K. | An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants | 2020-10-19 | 4573.0 | 256.0 | view text |
| cord-133453-23rfdkuw | Chen, Jiahui | Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies | 2020-10-13 | 8184.0 | 485.0 | view text |
| cord-260406-qvc2fb0c | Chen, Long | Severe Acute Respiratory Syndrome Coronavirus‐2 Spike Protein Nanogel as a Pro‐Antigen Strategy with Enhanced Protective Immune Responses | 2020-10-26 | nan | nan | view text |
| cord-252919-647zcjgu | Chen, Yun | Structure analysis of the receptor binding of 2019-nCoV | 2020-02-17 | 3436.0 | 185.0 | view text |
| cord-327654-9g8zcxaa | Chi, Xiaojing | Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain | 2020-09-10 | nan | nan | view text |
| cord-342557-a7q8vp8m | Chowdhury, Surid Mohammad | Antiviral Peptides as Promising Therapeutics against SARS-CoV-2 | 2020-10-23 | 3554.0 | 232.0 | view text |
| cord-256156-mywhe6w9 | Clausen, Thomas Mandel | SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 | 2020-09-14 | 8965.0 | 562.0 | view text |
| cord-331786-wgt7kg6f | Diego-Martin, Borja | Pilot production of SARS-CoV-2 related proteins in plants: a proof of concept for rapid repurposing of indoors farms into biomanufacturing facilities | 2020-10-13 | 7034.0 | 326.0 | view text |
| cord-315415-3aotsb2g | Dong, Jianbo | Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2 | 2020-10-20 | nan | nan | view text |
| cord-285900-3rr0j5tk | Du, Lanying | Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines | 2016-11-22 | nan | nan | view text |
| cord-328003-yovp8squ | Duan, Liangwei | The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens | 2020-10-07 | 7346.0 | 386.0 | view text |
| cord-310636-y7n22ykt | Garcia-Beltran, W. F. | COVID-19 neutralizing antibodies predict disease severity and survival | 2020-10-20 | nan | nan | view text |
| cord-267001-csgmc155 | George, Parakkal Jovvian | The Potency of an Anti-MERS Coronavirus Subunit Vaccine Depends on a Unique Combinatorial Adjuvant Formulation | 2020-05-27 | 7674.0 | 342.0 | view text |
| cord-310230-9wfb43gt | Ghorbani, Mahdi | Critical Sequence Hot-spots for Binding of nCOV-2019 to ACE2 as Evaluated by Molecular Simulations | 2020-06-27 | 3479.0 | 220.0 | view text |
| cord-346670-34wfy52f | Gobeil, Sophie M-C. | D614G mutation alters SARS-CoV-2 spike conformational dynamics and protease cleavage susceptibility at the S1/S2 junction | 2020-10-12 | 7065.0 | 359.0 | view text |
| cord-314676-ndke9agh | Gollapalli, Pavan | Pathway enrichment analysis of virus-host interactome and prioritization of novel compounds targeting the spike glycoprotein receptor binding domain–human angiotensin-converting enzyme 2 interface to combat SARS-CoV-2 | 2020-11-04 | nan | nan | view text |
| cord-305742-wf6qxplf | Gomez, Santiago A. | Binding of SARS–CoV–2 to cell receptors: a tale of molecular evolution | 2020-09-28 | nan | nan | view text |
| cord-348455-vcxalkeo | Graham, N. R. | Kinetics and Isotype Assessment of Antibodies Targeting the Spike Protein Receptor Binding Domain of SARS-CoV-2 In COVID-19 Patients as a function of Age and Biological Sex. | 2020-07-22 | 4105.0 | 283.0 | view text |
| cord-351760-698voi9y | Han, Hui-Ju | Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection | 2018-11-30 | 4144.0 | 206.0 | view text |
| cord-319590-f9qcabcx | Han, Yanxiao | Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2 | 2020-04-14 | nan | nan | view text |
| cord-333264-jdvb8px4 | Hanke, Leo | An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction | 2020-09-04 | 6380.0 | 380.0 | view text |
| cord-343185-lbmbp9ca | Hansen, C. B. | SARS-CoV-2 antibody responses determine disease severity in COVID-19 infected individuals | 2020-07-29 | 5349.0 | 332.0 | view text |
| cord-323514-jaom3p6s | He, Yuxian | A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity | 2006-05-26 | 4007.0 | 182.0 | view text |
| cord-296657-mymndjvd | Higuchi, Yusuke | High affinity modified ACE2 receptors prevent SARS-CoV-2 infection | 2020-09-16 | 3509.0 | 195.0 | view text |
| cord-281793-tj4m01s4 | Ho, Mitchell | Perspectives on the development of neutralizing antibodies against SARS-CoV-2 | 2020-05-20 | 3745.0 | 203.0 | view text |
| cord-333465-cha7ndv5 | Horspool, A. M. | Interplay of antibody and cytokine production reveals CXCL-13 as a potential novel biomarker of lethal SARS-CoV-2 infection | 2020-08-31 | 4309.0 | 286.0 | view text |
| cord-260412-yjr83ef6 | Hotez, Peter J. | Developing a low-cost and accessible COVID-19 vaccine for global health | 2020-07-29 | 2322.0 | 117.0 | view text |
| cord-309898-sju15hev | Hu, Yiwen | Comparative analysis of nanomechanical features of coronavirus spike proteins and correlation with lethality and infection rate | 2020-11-02 | nan | nan | view text |
| cord-262145-i29e3fge | Huang, Kuan-Ying A. | Breadth and function of antibody response to acute SARS-CoV-2 infection in humans | 2020-10-19 | 2949.0 | 207.0 | view text |
| cord-329011-spiuqngp | Huang, Yuan | Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19 | 2020-08-03 | 6045.0 | 340.0 | view text |
| cord-256572-sqz8yc7b | Huo, Jiandong | Neutralization of SARS-CoV-2 by destruction of the prefusion Spike | 2020-05-06 | 5378.0 | 313.0 | view text |
| cord-338517-1mxcssjj | Ishay, Yuval | Antibody response to SARS‐Co‐V‐2, diagnostic and therapeutic implications | 2020-08-26 | 7387.0 | 399.0 | view text |
| cord-301347-22lt6h40 | Jarvis, Matthew C. | Genomic and evolutionary inferences between American and global strains of porcine epidemic diarrhea virus | 2016-01-01 | 4256.0 | 218.0 | view text |
| cord-276493-hoaxv5e0 | Jeong, Gi Uk | Therapeutic Strategies Against COVID-19 and Structural Characterization of SARS-CoV-2: A Review | 2020-07-14 | 5687.0 | 363.0 | view text |
| cord-285758-c18arb6s | Jiang, Shibo | SARS Vaccine Development | 2005-07-17 | 2305.0 | 106.0 | view text |
| cord-292578-co5essuw | Johnson, Marina | Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2 | 2020-08-02 | nan | nan | view text |
| cord-296319-fwn97wds | Juno, J. A. | Immunogenic profile of SARS-CoV-2 spike in individuals recovered from COVID-19 | 2020-05-21 | nan | nan | view text |
| cord-306438-db2rqz4d | Kalathiya, Umesh | Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site | 2020-05-14 | nan | nan | view text |
| cord-015235-lv8mll28 | Kim, Hyun | Functional analysis of the receptor binding domain of SARS coronavirus S1 region and its monoclonal antibody | 2014-04-16 | 5855.0 | 323.0 | view text |
| cord-276833-haci44cy | Kim, Ju | Human β-defensin 2 is involved in CCR2-mediated Nod2 signal transduction, leading to activation of the innate immune response in macrophages | 2019-05-18 | 5369.0 | 292.0 | view text |
| cord-280941-ds6x0yym | Kim, Young-Seok | Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles | 2018-05-17 | 9411.0 | 491.0 | view text |
| cord-273891-7w334xgt | Kirchdoerfer, Robert N. | Receptor binding and proteolysis do not induce large conformational changes in the SARS-CoV spike | 2018-03-31 | 3300.0 | 170.0 | view text |
| cord-312560-onfabcfv | Klingler, J. | Role of IgM and IgA Antibodies to the Neutralization of SARS-CoV-2 | 2020-08-21 | 5861.0 | 353.0 | view text |
| cord-333703-1ku3jc9s | Kraus, Aurora | A zebrafish model for COVID-19 recapitulates olfactory and cardiovascular pathophysiologies caused by SARS-CoV-2 | 2020-11-08 | 8452.0 | 605.0 | view text |
| cord-339724-roj8ksvc | Lan, Jiaming | Tailoring Subunit Vaccine Immunity with Adjuvant Combinations and Delivery Routes Using the Middle East Respiratory Coronavirus (MERS-CoV) Receptor-Binding Domain as an Antigen | 2014-11-18 | 5017.0 | 249.0 | view text |
| cord-291790-z5rwznmv | Li, Qianqian | The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity | 2020-07-17 | nan | nan | view text |
| cord-332134-88wfcc3y | Li, Tingting | A potent synthetic nanobody targets RBD and protects mice from SARS-CoV-2 infection | 2020-09-24 | nan | nan | view text |
| cord-300847-ycuiso0g | Li, Wei | Rapid selection of a human monoclonal antibody that potently neutralizes SARS-CoV-2 in two animal models | 2020-06-02 | 2801.0 | 172.0 | view text |
| cord-339093-mwxkvwaz | Li, Wei | High potency of a bivalent human VH domain in SARS-CoV-2 animal models | 2020-09-04 | 11419.0 | 687.0 | view text |
| cord-340472-9ijlj4so | Li, Wenhui | Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2 | 2005-03-24 | 6610.0 | 297.0 | view text |
| cord-253438-k8iqv1jb | Li, Yujun | SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig | 2020-10-27 | 5339.0 | 327.0 | view text |
| cord-281536-8y7yxcp4 | Lim, Hocheol | Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method | 2020-10-08 | nan | nan | view text |
| cord-342312-rnq1hfsj | Liu, Bingfeng | Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies | 2020-09-16 | 1127.0 | 63.0 | view text |
| cord-258902-h0wrs01h | Liu, Xianglei | Enhanced Elicitation of Potent Neutralizing Antibodies by the SARS-CoV-2 Spike Receptor Binding Domain Fc Fusion Protein in Mice | 2020-09-22 | 5015.0 | 268.0 | view text |
| cord-263481-w5ytp1q7 | Lokman, Syed Mohammad | Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: A computational biology approach | 2020-06-02 | 3013.0 | 171.0 | view text |
| cord-273893-3nd6ptrg | Lu, Guangwen | Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26 | 2013-07-07 | 4674.0 | 260.0 | view text |
| cord-326282-uxn64olw | Lu, Maolin | Real-time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles | 2020-09-13 | nan | nan | view text |
| cord-297747-kifqgskc | Lupala, Cecylia S. | Computational simulations reveal the binding dynamics between human ACE2 and the receptor binding domain of SARS-CoV-2 spike protein | 2020-03-27 | 4522.0 | 231.0 | view text |
| cord-300784-4jeaqqn9 | Ma, Huan | COVID-19 diagnosis and study of serum SARS-CoV-2 specific IgA, IgM and IgG by a quantitative and sensitive immunoassay | 2020-04-22 | nan | nan | view text |
| cord-335316-x2t5h5gu | Madariaga, M. L. L. | Clinical predictors of donor antibody titer and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial | 2020-06-23 | 4328.0 | 234.0 | view text |
| cord-323967-2mo915u1 | Miersch, Shane | Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations | 2020-11-01 | nan | nan | view text |
| cord-296187-nnv2e7gr | Mulgaonkar, Nirmitee | Bcr-Abl tyrosine kinase inhibitor imatinib as a potential drug for COVID-19 | 2020-08-18 | nan | nan | view text |
| cord-291420-40xsypzt | Nelson-Sathi, Shijulal | Mutational landscape and in silico structure models of SARS-CoV-2 Spike Receptor Binding Domain reveal key molecular determinants for virus-host interaction | 2020-10-01 | 2274.0 | 145.0 | view text |
| cord-260334-xo8ruswo | New, R.R.C. | Antibody-mediated protection against MERS-CoV in the murine model() | 2019-07-09 | 5748.0 | 247.0 | view text |
| cord-268894-amfv3z2y | Nguyen-Contant, Phuong | S protein-reactive IgG and memory B cell production after human SARS-CoV-2 infection includes broad reactivity to the S2 subunit | 2020-07-21 | nan | nan | view text |
| cord-292883-7hvq9qaj | Nguyen-Contant, Phuong | S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit | 2020-09-25 | nan | nan | view text |
| cord-341396-0tn06al2 | Ni, Ling | Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals | 2020-05-03 | 2100.0 | 128.0 | view text |
| cord-315437-h6xjudm0 | Nyon, Mun Peak | Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen | 2018-03-27 | nan | nan | view text |
| cord-320238-qbjrlog1 | Okba, Nisreen M. A. | Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV | 2020-05-29 | nan | nan | view text |
| cord-332948-h297ukuu | Olotu, Fisayo A. | Leaving no stone unturned: Allosteric targeting of SARS-CoV-2 Spike protein at putative druggable sites disrupts human angiotensin-converting enzyme interactions at the receptor binding domain. | 2020-10-16 | 5176.0 | 315.0 | view text |
| cord-309411-2dfiwo65 | Paris, Kristina A. | Loss of pH switch unique to SARS-CoV2 supports unfamiliar virus pathology | 2020-06-23 | nan | nan | view text |
| cord-332855-u0amf1oh | Parsons, Lisa M. | Glycosylation of the viral attachment protein of avian coronavirus is essential for host cell and receptor binding | 2019-03-22 | 6964.0 | 417.0 | view text |
| cord-287205-k64svq6n | Pollet, Jeroen | SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice | 2020-11-05 | nan | nan | view text |
| cord-309182-t9ywnshj | Premkumar, Lakshmanane | The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients | 2020-06-11 | nan | nan | view text |
| cord-311035-s3tkbh9r | Procko, Erik | Deep mutagenesis in the study of COVID-19: a technical overview for the proteomics community | 2020-10-21 | 4033.0 | 210.0 | view text |
| cord-336150-l8w7xk0b | Rathore, Jitendra Singh | Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a newly emerged pathogen: an overview | 2020-08-25 | 7362.0 | 399.0 | view text |
| cord-278869-7zr1118b | Ravichandran, Supriya | Antibody repertoire induced by SARS-CoV-2 spike protein immunogens | 2020-05-13 | 2370.0 | 142.0 | view text |
| cord-254735-8reu45yz | Reguera, Juan | Structural Bases of Coronavirus Attachment to Host Aminopeptidase N and Its Inhibition by Neutralizing Antibodies | 2012-08-02 | 8064.0 | 410.0 | view text |
| cord-321854-cy8vyb6j | Ripperger, Tyler J. | Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low Prevalence Communities and Reveal Durable Humoral Immunity. | 2020-10-14 | nan | nan | view text |
| cord-353161-mtq6yh25 | Rodrigues, João PGLM | Insights on cross-species transmission of SARS-CoV-2 from structural modeling | 2020-06-05 | 6169.0 | 369.0 | view text |
| cord-263167-es806qhz | Rogers, Thomas F. | Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model | 2020-06-15 | 4512.0 | 249.0 | view text |
| cord-263090-29n9tsk9 | Roy, Susmita | Dynamical asymmetry exposes 2019-nCoV prefusion spike | 2020-04-21 | 4573.0 | 331.0 | view text |
| cord-102920-z5q3wo7v | Sang, Eric R. | Integrate Structural Analysis, Isoform Diversity, and Interferon-Inductive Propensity of ACE2 to Refine SARS-CoV2 Susceptibility Prediction in Vertebrates | 2020-06-28 | 6437.0 | 316.0 | view text |
| cord-265697-bbvlowyo | Sang, Eric R. | Integrate structural analysis, isoform diversity, and interferon-inductive propensity of ACE2 to predict SARS-CoV2 susceptibility in vertebrates | 2020-08-31 | nan | nan | view text |
| cord-288761-fyvr0tc1 | Santiago, César | Allosteric inhibition of aminopeptidase N functions related to tumor growth and virus infection | 2017-04-10 | 5859.0 | 342.0 | view text |
| cord-355728-wivk0bm0 | Schoof, Michael | An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation | 2020-08-17 | 3613.0 | 377.0 | view text |
| cord-319571-fspmgg4s | Sehailia, Moussa | Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19 | 2020-07-22 | nan | nan | view text |
| cord-338538-uea9kwge | Shehata, Mahmoud M. | Bacterial Outer Membrane Vesicles (OMVs)-Based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoV | 2019-05-28 | 6278.0 | 319.0 | view text |
| cord-103940-a2cqw8kg | Shi, Yuejun | Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins | 2020-06-09 | 3207.0 | 216.0 | view text |
| cord-290290-wyx9ib7s | Sinegubova, Maria V. | High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector | 2020-11-05 | nan | nan | view text |
| cord-281005-6gi18vka | Singh, Praveen Kumar | Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development | 2020-09-01 | 3161.0 | 203.0 | view text |
| cord-274480-aywdmj6o | Song, Wenfei | Identification of residues on human receptor DPP4 critical for MERS-CoV binding and entry | 2014-10-21 | 2815.0 | 147.0 | view text |
| cord-303868-aes92l6s | Steffen, Tara L. | The receptor binding domain of SARS-CoV-2 spike is the key target of neutralizing antibody in human polyclonal sera | 2020-08-22 | nan | nan | view text |
| cord-297072-f5lmstyn | Struck, Anna-Winona | A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2 | 2012-01-16 | 5088.0 | 302.0 | view text |
| cord-335118-oa9jfots | Taka, E. | Critical Interactions Between the SARS-CoV-2 Spike Glycoprotein and the Human ACE2 Receptor | 2020-09-21 | 5264.0 | 344.0 | view text |
| cord-321166-nvphu1fm | Thomson, Emma C. | The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity | 2020-11-05 | nan | nan | view text |
| cord-314574-3e6u4aza | Tian, Xiaolong | Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody | 2020-02-17 | 1816.0 | 88.0 | view text |
| cord-259185-qg4jwbes | Vadlamani, B. S. | Functionalized TiO2 nanotube-based Electrochemical Biosensor for Rapid Detection of SARS-CoV-2 | 2020-09-09 | 3988.0 | 249.0 | view text |
| cord-344180-v8xs5ej8 | Vadlamani, Bhaskar S. | Functionalized TiO(2) Nanotube-Based Electrochemical Biosensor for Rapid Detection of SARS-CoV-2 | 2020-10-17 | 5150.0 | 280.0 | view text |
| cord-284102-rovyvv45 | Wagner, Teresa R. | NeutrobodyPlex - Nanobodies to monitor a SARS-CoV-2 neutralizing immune response | 2020-09-28 | 2910.0 | 190.0 | view text |
| cord-308428-zw26usmh | Walter, Justin D. | Highly potent bispecific sybodies neutralize SARS-CoV-2 | 2020-11-10 | 10526.0 | 580.0 | view text |
| cord-318444-sgm24q1i | Walter, Justin D. | Sybodies targeting the SARS-CoV-2 receptor-binding domain | 2020-05-16 | nan | nan | view text |
| cord-352934-ypls4zau | Wan, Jinkai | Human IgG neutralizing monoclonal antibodies block SARS-CoV-2 infection | 2020-07-03 | 2406.0 | 151.0 | view text |
| cord-328578-9qzo18v3 | Wang, Yunfei | SARS‐CoV‐2 S1 is superior to the RBD as a COVID‐19 subunit vaccine antigen | 2020-07-21 | 1998.0 | 110.0 | view text |
| cord-295482-qffg6r91 | Wong, Alan H. M. | Receptor-binding loops in alphacoronavirus adaptation and evolution | 2017-11-23 | 6609.0 | 373.0 | view text |
| cord-344871-486sk4wc | Wu, Jianping | Biochemical and structural characterization of the interface mediating interaction between the influenza A virus non-structural protein-1 and a monoclonal antibody | 2016-09-16 | 6992.0 | 379.0 | view text |
| cord-321918-9jwma2y6 | Xiu, Siyu | Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities | 2020-06-15 | 10526.0 | 621.0 | view text |
| cord-261877-4y37676n | Xu, Cong | Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM | 2020-06-30 | 8754.0 | 505.0 | view text |
| cord-274280-x5s4l0pp | Yang, Jinsung | Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor | 2020-09-11 | nan | nan | view text |
| cord-354868-pqn59ojj | Yao, Hebang | A high-affinity RBD-targeting nanobody improves fusion partner’s potency against SARS-CoV-2 | 2020-09-25 | 3231.0 | 236.0 | view text |
| cord-355807-q3bngari | Yepes-Pérez, Andres F. | Uncaria tomentosa (cat’s claw): a promising herbal medicine against SARS-CoV-2/ACE-2 junction and SARS-CoV-2 spike protein based on molecular modeling | 2020-10-29 | 8807.0 | 453.0 | view text |
| cord-275185-9br8lwma | Zeng, Hao | The efficacy assessment of convalescent plasma therapy for COVID-19 patients: a multi-center case series | 2020-10-06 | 6613.0 | 360.0 | view text |
| cord-024319-isbqs7hg | Zeng, Xin | Isolation of a human monoclonal antibody specific for the receptor binding domain of SARS-CoV-2 using a competitive phage biopanning strategy | 2020-04-30 | 3036.0 | 174.0 | view text |
| cord-253447-4w6caxwu | Zeng, Xin | Blocking antibodies against SARS-CoV-2 RBD isolated from a phage display antibody library using a competitive biopanning strategy | 2020-04-20 | 2866.0 | 161.0 | view text |
| cord-308310-wtmjt3hf | Zha, Lisha | Development of a COVID-19 vaccine based on the receptor binding domain displayed on virus-like particles | 2020-05-14 | 2012.0 | 110.0 | view text |
| cord-332185-a96r1k7a | Zhang, Shuyuan | Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution | 2020-09-22 | nan | nan | view text |
| cord-268144-maa8c4a4 | Zhang, Yuan | Computational characterization and design of SARS coronavirus receptor recognition and antibody neutralization | 2007-02-17 | 2548.0 | 129.0 | view text |
| cord-347587-auook38y | Zhao, Guangyu | A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV | 2018-08-29 | 6554.0 | 363.0 | view text |
| cord-183197-dxmto1tu | Zhao, Tom Y. | Tetracycline as an inhibitor to the coronavirus SARS-CoV-2 | 2020-08-13 | 1587.0 | 83.0 | view text |
| cord-263042-qdmunb9l | Zhao, Yongkun | Passive immunotherapy for Middle East Respiratory Syndrome coronavirus infection with equine immunoglobulin or immunoglobulin fragments in a mouse model | 2016-11-24 | 3370.0 | 187.0 | view text |
| cord-327711-welf0eb1 | Zhou, Daming | Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient | 2020-06-13 | 4847.0 | 290.0 | view text |
| cord-285039-9piio754 | Zhou, Haixia | Crystallization and Structural Determination of the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein | 2019-09-14 | 1940.0 | 144.0 | view text |
| cord-343107-oj1re34k | Zhou, Haixia | Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein | 2019-07-11 | 8592.0 | 421.0 | view text |
| cord-352527-eeyqh9nc | Zhou, Yusen | Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain | 2019-01-14 | 5834.0 | 277.0 | view text |
| cord-329392-fufattj8 | den Hartog, Gerco | SARS-CoV-2–Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence | 2020-08-08 | nan | nan | view text |